1. Home
  2. SMJF vs GANX Comparison

SMJF vs GANX Comparison

Compare SMJF & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$3.35

Market Cap

88.7M

Sector

N/A

ML Signal

N/A

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMJF
GANX
Founded
1988
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
78.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SMJF
GANX
Price
$3.35
$1.79
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
746.9K
511.0K
Earning Date
09-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
N/A
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$68.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.41
52 Week High
$5.70
$4.34

Technical Indicators

Market Signals
Indicator
SMJF
GANX
Relative Strength Index (RSI) 54.17 40.43
Support Level $2.94 $1.73
Resistance Level $3.72 $2.09
Average True Range (ATR) 0.14 0.11
MACD 0.01 -0.01
Stochastic Oscillator 79.84 19.41

Price Performance

Historical Comparison
SMJF
GANX

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: